Breast Cancer Flashcards
how common is breast cancer death in women compared to other cancers
- lung
- cancer
are breast cancer cases / deaths going up?
no, they have decreased
do most breast cancer pts have risk factors?
no, 60%+ do not have risk factors
risk factors for breast cancer (11)
increased age
family history
personal history
radiation
early menarche/late menopause
oral contraceptive / HRT
alcohol
breast biopsies
age >30 first birth
elevated BMI
diet (soy protective)
what percentage of breast cancers are familial
5-10%
what are the genes that are linked to breast cancer genetics
tumor supressors:
BRCA-1
BRCA-2
what is the GAIL risk model
RR% of getting breast cancer
invasive types of breast cancer
invasive ductal carcinoma
invasive lobular carcinoma
most common type of breast cancer
invasive ductal carcinoma (70%)
non-invasive breast cancer types
ductal carcinoma in-situ
lobular carcinoma in-situ
inflammatory breast cancer description
aggressive form with rapid onset and poor prognosis
days and weeks onset
inflammatory breast cancer symptoms
edema
redness
warmth
inflammation
orange peel look
breast cancer most common presentation
90% will have painless lump
how many will develop metatstatic
50%
what does FISH testing test for
HER2
what tests are for HER2
FISH and IHC
what is the oncodx
determines likelyhood that the cancer will return and if patient would benefit from chemo
what kind of patients can we use oncotype dx on
ER+ HER2- newer diagnosis low stage
low risk wouldnt benefit from chemo score
under 26
high risk would benefit from chemo score
26+
under 50 but score of what means chemo would be beneficial
16-25
who mainly gets chemo before surgery
Stage IIIB and IIIC
who mainly gets chemo after surgery (Stage)
I II IIIA
stage IV surgery?
no, only for symptomatic relief
adjuvant means what
after surgery
neoadjuvant means what
before surgery
radiation comes before or after surgery
after
what stages are we trying to cure
I, II, III
which HER2 patients should get chemo
tumor >0.6 cm
HER2 targeted, chemo, hormone
HER2+ with tumor <0.5 reccomendation therapy
HER2 targeted
+/- chemo
endocrine therapy
SERM drug
tamoxifen
oophrectomy reccomended for who
premenopausal women with intact ovaries
LNRH analogs reccommended instead of what
taking out ovaries
LNRH analog drugs
leuprolide
goserelin
side effect of leuprolide and goserelin
FSH and LH surge, hot flashes first 2-4 weeks
aromatase inhibitors for pre or post meno
post
aromatase inhibitors side effects
hot flashes
osteoporosis
muscle aches and pains
aromatase inhibitor drugs
anastrazole
letrozole
exemestane
premenopausal with intact ovaries hormonal treatment
tamoxifen for 5 years THEN 5 more years of tamoxifen or AI if no ovaries
premenopausal but ovary supression / ovary out
tamoxifen or AI x 5 years then either for 5 more years
if postmenopausal at diagnosis whats the ideal treatment
AI for 5 years + 5 more years
standard chemo length
4-6 cycles given every 3-4 weeks
most common chemo classes given in breast cancer
anthracyclines
taxanes
HER2 negative chemo regimens
AC w paclitaxel
TC
what is AC with paclitaxel consist of
doxorubicin
cyclophosphamide
paclitaxel
every 2 weeks with CSFs
what is TC consist of and why would we use this
docetaxel
cyclophosphamide
if extensive cardiac history
what is dose dense
same dose shorter interval
HER2 negative patient with cardiac tox should do what
docetaxel + cyclophosphamide
HER2+ patients older treatment
APT
paclitaxel
trastuzumab (1 year)
HER2+ patients who are younger
TCH + P
docetaxel
carboplatin
trastuzumab
pertuzumab
how long should pts be on trastuzumab
1 yearr
triple negative chemo
paclitaxel
carboplatin
pemborlizumab
THEN
doxorubiucin
cyclophosphamide
pembrolizumab
how long should pembrolizumab be going for
1 year
er+ metastatic pts with long disease free survival, chemo or hormone?
hormone therapy
metastatic pts with short disease free survival agent
chemotherapy
metastatic HER2+ chemo regimen
trastuzumab
pertuzumab
docetaxel / paclitaxel
how long to continue trastuzumab and pertuzumab in metastatic disease
not a year
metastatic second line HER2 low
fam-trastuzumab
fam-trastuzumab used in who
1+ HER2 in metastatic
fam-trastuzumab side effect
shortness of breath
metastatic triple negative treatment
platinum
pemborlizumab if 10+ score
what do we check if putting someone on CDK4/6 inhibitors
CBC monthly
which CDK4/6 has QTC prolongations
ribociclib
which CDK4/6 has diarrhea
abemaciclib
first and second line treatment in ER+ HER2- metastatic
- AI + CDK4/6
- everolimus + fulvestrant
what age should women start thinking about mammograms
40 years
what age should mammograms be yearly
45-54
which drugs can be used as preventative in high risk pts
tamoxifen
raloxifene